Citrate excretion in spinal cord patients

Area of Science:

• Nephrology
• Urology
• Biochemistry

Background:

• Low urinary citrate is a significant risk factor for calcium-based renal stone disease.
• Patients with spinal cord lesions often exhibit low urinary citrate excretion, necessitating investigation into causative factors.

Purpose of the Study:

• To identify the key factors contributing to the reduced urinary citrate excretion observed in patients with spinal cord lesions.
• To elucidate the relationship between urinary citrate levels and other biochemical and physiological parameters in this patient group.

Main Methods:

• Studied 30 male patients with spinal cord lesions using comprehensive blood and urine biochemistry analysis.
• Assessed plasma and urinary citrate, urinary potassium, urinary sodium, urinary volume, and performed urine bacteriological cultures.
• Utilized these parameters to differentiate between patients with and without urinary stone disease.

Main Results:

• Urinary potassium emerged as the most critical factor associated with urinary citrate levels.
• Urinary stone disease and variations in urinary volume were also significant contributors to citrate excretion variability.
• Analysis of plasma/urinary citrate, urinary sodium, and urine cultures successfully distinguished the 7 stone formers from other patients.

Conclusions:

• Urinary potassium is a primary determinant of low urinary citrate in spinal cord lesion patients.
• Urinary volume and the presence of stone disease are important co-factors influencing citrate excretion.
• Biochemical and microbiological urine analysis can effectively differentiate stone formers in this population.